Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
Holding YMAB?
Track your performance easily
Y-Mabs Therapeutics (YMAB) Ownership Overview
29.85% Insiders
10.06% Mutual Funds
9.48% Other Institutional Investors
― ETFs
50.60% Public Companies and
Individual Investors
The ownership structure of Y-Mabs Therapeutics (YMAB) stock is a mix of institutional, retail, and individual investors. , 29.85% is owned by Insiders, and 50.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 11, 2024 | Thomas Gad Cbo,director | xxxxxxxxxxxxx | $841050 |
| Jun 11, 2024 | Gerard Ber Director | xxxxxxxxxxxxx | $8664 |
| May 31, 2024 | Bo Kruse Evp, Cfo, Secry & Treas | xxxxxxxxxxxxx | $723055 |
| May 23, 2024 | Thomas Gad Cbo,director | xxxxxxxxxxxxx | $395563 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $305801 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,792,768 | Institution | 4.09% | 22,355,817 | |
| 1,785,795 | Institution | 4.07% | 22,268,864 | |
| 1,623,095 | Institution | 3.70% | 20,239,995 | |
| 394,826 | Institution | 0.90% | 4,923,480 | |
| 309,878 | Institution | 0.71% | 3,864,179 | |
| 274,806 | Institution | 0.63% | 3,426,831 | |
| 252,088 | Institution | 0.57% | 3,143,537 | |
| 210,245 | Institution | 0.48% | 2,621,755 | |
| 165,907 | Institution | 0.38% | 2,068,860 | |
| 161,416 | Institution | 0.37% | 2,012,858 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,623,095 | Institution | 3.70% | 20,239,995 | |
| 394,826 | Institution | 0.90% | 4,923,480 | |
| 309,878 | Institution | 0.71% | 3,864,179 | |
| 274,806 | Institution | 0.63% | 3,426,831 | |
| 252,088 | Institution | 0.57% | 3,143,537 | |
| 210,245 | Institution | 0.48% | 2,621,755 | |
| 165,907 | Institution | 0.38% | 2,068,860 | |
| 161,416 | Institution | 0.37% | 2,012,858 | |
| 119,150 | Institution | 0.27% | 1,485,801 | |
| 99,319 | Institution | 0.23% | 1,238,508 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 997,061 | Institution | 2.27% | 12,064,438 | |
| 901,919 | Institution | 2.06% | 10,886,162 | |
| 465,950 | Institution | 1.06% | 5,637,995 | |
| 324,773 | Institution | 0.74% | 4,049,919 | |
| 281,679 | Institution | 0.64% | 3,512,537 | |
| 137,783 | Institution | 0.31% | 1,667,174 | |
| 134,760 | Institution | 0.31% | 1,626,553 | |
| 103,213 | Institution | 0.24% | 1,248,877 | |
| 79,301 | Institution | 0.18% | 988,883 | |
| 66,476 | Institution | 0.15% | 802,365 |
FAQ
Who Owns Y-Mabs Therapeutics (YMAB)?
According to the latest TipRanks data, approximately 9.48% of the company's stock is held by institutional investors, 29.85% is held by insiders, and 50.60% is held by retail investors.
What percentage of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.48% of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors.
What percentage of Y-Mabs Therapeutics (YMAB) stock is held by retail investors?
According to the latest TipRanks data, approximately 50.60% of Y-Mabs Therapeutics (YMAB) stock is held by retail investors.
Who owns the most shares of Y-Mabs Therapeutics (YMAB)?
Vanguard owns the most shares of Y-Mabs Therapeutics (YMAB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.